Agios Pharmaceuticals
AGIO
#4690
Rank
HK$16.11 B
Marketcap
HK$274.98
Share price
0.89%
Change (1 day)
36.65%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2025 (TTM): -HK$3.69 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are HK$54.02 Million. a decrease over its 2024 earnings that were of -HK$3.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 -HK$3.7 Billion10.9%
2024 -HK$3.34 Billion8.75%
2023 -HK$3.07 Billion0.63%
2022 -HK$3.05 Billion2.81%
2021 -HK$2.97 Billion10.58%
2020 -HK$2.69 Billion-18.41%
2019 -HK$3.29 Billion15.72%
2018 -HK$2.84 Billion12.99%
2017 -HK$2.52 Billion59.61%
2016 -HK$1.58 Billion69.32%
2015 -HK$0.93 Billion119.28%
2014 -HK$0.43 Billion39.22%
2013 -HK$0.31 Billion69.1%
2012 -HK$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$79.82 B-2,258.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$201.52 B-5,549.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$77.50 B-2,195.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-HK$1.09 Billion-70.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$7.37 B-299.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.77 B-202.19%๐Ÿ‡บ๐Ÿ‡ธ USA